COVID-19-induced psoriatic arthritis: a case report
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which may lead to uncontrolled immune activation and cytokine response in some. The pattern of pro-inflammatory cytokines is similar to that which has been observed to...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_5fa62e6d438547d9bffc356badde7b5e | ||
042 | |a dc | ||
100 | 1 | 0 | |a Francis Essien |e author |
700 | 1 | 0 | |a Lisa Chastant |e author |
700 | 1 | 0 | |a Collen McNulty |e author |
700 | 1 | 0 | |a Matthew Hubbard |e author |
700 | 1 | 0 | |a Luria Lynette |e author |
700 | 1 | 0 | |a Matthew Carroll |e author |
245 | 0 | 0 | |a COVID-19-induced psoriatic arthritis: a case report |
260 | |b SAGE Publishing, |c 2022-05-01T00:00:00Z. | ||
500 | |a 2040-6231 | ||
500 | |a 10.1177/20406223221099333 | ||
520 | |a Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which may lead to uncontrolled immune activation and cytokine response in some. The pattern of pro-inflammatory cytokines is similar to that which has been observed to be involved in rheumatic diseases and target treatments. Viral arthritis is common with a wide variety in spectrum ranging from arthralgia to spurious and chronic arthritis. However, recent studies have demonstrated a correlation with endemic coronaviruses and increased risk of developing rheumatoid arthritis (RA). Cases are being identified that describe a post-COVID reactive; however, to date, no report has been published describing the onset of psoriasis and concomitant development of psoriatic arthritis after COVID-19 infection. We report an interesting case of psoriatic arthritis in a post-COVID-19 infection patient with review of the current literature. | ||
546 | |a EN | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Therapeutic Advances in Chronic Disease, Vol 13 (2022) | |
787 | 0 | |n https://doi.org/10.1177/20406223221099333 | |
787 | 0 | |n https://doaj.org/toc/2040-6231 | |
856 | 4 | 1 | |u https://doaj.org/article/5fa62e6d438547d9bffc356badde7b5e |z Connect to this object online. |